Conclusions: Fetuses complicated with neonatal respiratory disorder showed significantly lower LLSIR than that of normal pulmonary function, and LLSIR seems to be a useful MRI parameter to predict fetal functional pulmonary hypoplasia. This result indicates that low LLSIR might reflect the histological characteristics of hypoplastic lung structures.
Objectives:
To investigate the different phenotype of short limb abnormalities related to different mutations in the same FGFR3 (fibroblast growth factor receptor 3, FGFR3) and to provide a theoretical basis for prenatal diagnosis and genetic counselling Methods: This study enrolled 13 cases of fetal short-limb dysplasia that were identified by ultrasound examination at Beijing Obstetrics and Gynecology Hospital from January 2015 to December 2017. All cases has been diagnosed with known pathogenic heterozygous mutations of FGFR3. For all cases, fetal umbilical cord blood, amniotic fluid or abortion tissues were retained. We sequentially conducted fetal chromosome examination, whole-genome sequencing, targeted gene sequencing and examined 363 genes related to skeletal development abnormalities. At the same time, parents' blood samples were retained for Sanger sequencing validation. X-ray and pathological examination were performed after termination of pregnancy. Results: 13 cases with FGFR3 gene heterozygous known mutation, distributed in 4 regions of c.742C>T (p.Arg248Cys), c.1144G>A (p.Gly382Arg), c.1124A>G (p.Tyr375Cys) and c.2426G>C (p.X809S, 101). Finally, 9 cases of were diagnosed as Thanatophoric dysplasia (TD), 4 cases were diagnosed as achondroplasia (ACH). Genetic testing via 1st-generation sequencing for all cases confirmed that the mutations were all de novo mutations, and neither parents carried the mutations. And natural conception was suggested for the patients. Among them, 3 patients had delivered healthy baby before, and 4 patients had delivered healthy baby after induction. Conclusions: Analysis of different cite gene diagnosis of FGFR3 can eventually clarify the classification of the diseases so as to provide patients with more comprehensive prenatal diagnosis and genetic counselling and to offer a theoretical basis for early intervention of birth defects and assessment of subsequent fertility risks. Objectives: To evaluate agreement between prenatal and postnatal diagnosis of congenital lung malformations (CLM).
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Methods:
We included all liveborn patients with a prenatal ultrasound diagnosis of congenital pulmonary airway malformation (CPAM), bronchopulmonary sequestration (BPS) and/or bronchogenic cysts (BC) between 2000 and 2015. The postnatal diagnosis, including congenital lobar emphysema (CLE), was made using computed tomography (CT) and/or histology. Results: The 112 patients were prenatally diagnosed at (mean±SD) 21.6±3.4 weeks' gestation and born at 39.2±1.6 weeks. We excluded 17 patients: 10 did not receive postnatal CT imaging or histology examination and in 7 patients CT did not show any CLM. In 95 remaining patients, postnatal diagnosis was made by CT in 66 (69%) and by histology following surgical resection in 29 (31%). Correct diagnoses were made in 72/95 (76%). In 50 of these, prenatal diagnoses were completely confirmed and in 22 partially, i.e. hybrid or inconclusive diagnosis (table) . Conclusions: The level of agreement between prenatal and postnatal diagnosis is suboptimal. Postnatal CT imaging should therefore be performed in every child with prenatally diagnosed CLM.
